BARDINI, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 4.237
EU - Europa 2.356
AS - Asia 2.284
SA - Sud America 386
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 9.319
Nazione #
US - Stati Uniti d'America 4.008
SG - Singapore 785
IT - Italia 662
CN - Cina 597
RU - Federazione Russa 304
HK - Hong Kong 289
DE - Germania 278
BR - Brasile 266
SE - Svezia 238
VN - Vietnam 234
IE - Irlanda 226
CA - Canada 194
UA - Ucraina 142
GB - Regno Unito 112
IN - India 79
FR - Francia 78
ES - Italia 65
FI - Finlandia 60
NL - Olanda 45
AT - Austria 41
AR - Argentina 39
BD - Bangladesh 39
KR - Corea 37
EC - Ecuador 32
ID - Indonesia 32
IQ - Iraq 31
TR - Turchia 23
MX - Messico 22
SA - Arabia Saudita 21
PL - Polonia 20
DK - Danimarca 18
BE - Belgio 17
ZA - Sudafrica 17
JP - Giappone 16
UZ - Uzbekistan 16
CO - Colombia 15
PT - Portogallo 13
PH - Filippine 12
PK - Pakistan 12
VE - Venezuela 11
CH - Svizzera 10
KE - Kenya 8
LT - Lituania 7
PE - Perù 7
PY - Paraguay 7
TW - Taiwan 7
EG - Egitto 6
KZ - Kazakistan 6
JO - Giordania 5
NP - Nepal 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
GR - Grecia 4
IL - Israele 4
IR - Iran 4
MA - Marocco 4
MY - Malesia 4
RO - Romania 4
AO - Angola 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CL - Cile 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
NO - Norvegia 3
OM - Oman 3
TH - Thailandia 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EU - Europa 2
GD - Grenada 2
LB - Libano 2
LY - Libia 2
PA - Panama 2
QA - Qatar 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 9.319
Città #
Ann Arbor 469
Singapore 446
Ashburn 418
Hong Kong 280
Chandler 246
Fairfield 244
Dublin 224
San Jose 223
Woodbridge 209
Houston 208
Frankfurt am Main 167
Wilmington 147
Milan 140
Toronto 134
Jacksonville 132
New York 126
Beijing 106
Dearborn 94
Seattle 89
Ho Chi Minh City 83
Cambridge 74
Santa Clara 70
Los Angeles 66
Chicago 62
Princeton 61
Dallas 60
The Dalles 59
Hefei 55
Nanjing 52
Hanoi 46
Lauterbourg 37
Moscow 35
Vienna 35
Seoul 34
São Paulo 32
Shanghai 31
Rome 30
Lawrence 27
Orem 26
Barcelona 23
Guangzhou 23
Buffalo 22
Chennai 22
Jakarta 21
Lachine 21
Munich 20
London 19
San Diego 19
Altamura 18
Council Bluffs 18
Helsinki 18
Andover 17
Brooklyn 17
Shenyang 17
Denver 16
Nanchang 15
Tashkent 15
Warsaw 15
Brussels 14
Fremont 14
Montreal 14
Naples 14
Phoenix 14
Quito 14
Stockholm 14
Tianjin 14
Bari 12
Hangzhou 12
Rio de Janeiro 12
Sesto San Giovanni 12
Boston 11
Dong Ket 11
Guayaquil 11
Johannesburg 11
Manchester 11
Nuremberg 11
Poplar 11
Turku 11
Lissone 10
Norwalk 10
Tokyo 10
Baghdad 9
Brasília 9
Jinan 9
Riyadh 9
Salt Lake City 9
Allentown 8
Changsha 8
Columbus 8
Florence 8
Jeddah 8
Lappeenranta 8
Nairobi 8
Perugia 8
Zurich 8
Ankara 7
Atlanta 7
Belo Horizonte 7
Cagliari 7
Hebei 7
Totale 5.863
Nome #
Infant ALL with MLL-AF4 is sustained by t(4;11) as the sole genetic abnormality, and it is initiated in mice by phenotypically and functionally distinct leukemic stem cell subsets 596
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 406
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 375
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 370
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 340
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL 337
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLL-r B-ALL by regulating NR3C1 expression 329
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 303
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 298
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 278
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients 268
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement 268
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 256
Effects of C/EBPalpha and C/EBPbeta in BCR/ABL-Expressing Cells: Differences and Similarities 253
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 242
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 237
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 236
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency 236
In Infant ALL with t(4;11)/MLL-AF4 Multiple and Phenotypically Distinct CD19+ BM Subsets Initiate Leukemia in NOD/SCID Mice 222
Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients 218
The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia 212
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia 205
Expression of CCL9/MIP-1bold italic gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells 199
Generazione di modelli in vivo per l'identificazione e lo studio di clonalità delle cellule staminali leucemiche nella LAL infant MLL-AF4 positiva 199
LAL infant introduces a new specific genomic profile 196
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 195
Correction to: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (Leukemia, (2018), 32, 3, (633-644), 10.1038/leu.2017.294) 194
Unique genomic profile of infant all patients 192
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease 191
Identification and characterization of candidate L-ICs IN MLL-AF4 infant all 190
In infant all with t(4;11)/mll-af4 multiple and phenotypically distinct bm subsets initiate leukemia into nod/scid mice 188
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 188
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 185
Oligoclonal origin of functionally distinct leukemic stem cells in infant acute lymphoblastic leukemia 183
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia 173
Inducible activation of C/EBPb, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells 167
Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment is dependent on Stearoyl CoA desaturase 164
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients 146
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome 97
Totale 9.532
Categoria #
all - tutte 28.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 0 0 0 0 0 0 46 47
2021/2022441 33 35 35 30 42 68 14 24 19 46 20 75
2022/2023920 86 275 86 74 51 155 14 55 76 1 35 12
2023/2024660 26 30 41 35 75 178 122 31 44 14 20 44
2024/20251.480 79 120 65 90 93 39 110 35 172 266 141 270
2025/20263.455 438 195 311 468 430 190 418 187 251 361 206 0
Totale 9.532